In another study, IL-6 modulated the immune status of TME, increasing the antitumor effector function of CD8 + T cells and IL12 production by CD11c + dendritic cells, leading to increased metastatic colonization of colorectal cancer cells [59]. Here, ITGAX is linked to colorectal cancer.